UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 320

Sortiert nach

GPER agonist dilates mesenteric arteries via PI3K-Akt-eNOS and potassium channels in both sexes

Life Sciences, 2017-08, Vol.183, p.21-27

2017

Link zum Volltext

Verfügbarkeit prüfen

Inhibitory effects of cortisone and hydrocortisone on human Kv1.5 channel currents

European journal of pharmacology, 2015-01, Vol.746, p.158-166

2015

Link zum Volltext

Verfügbarkeit prüfen

K+ Channels Expression in Hypertension After Arterial Injury, and Effect of Selective Kv1.3 Blockade with PAP-1 on Intimal Hyperplasia Formation

Cardiovascular drugs and therapy, 2014-12, Vol.28 (6), p.501-511

2014

Link zum Volltext

Verfügbarkeit prüfen

HMR 1556, A Potent and Selective Blocker of Slowly Activating Delayed Rectifier Potassium Current

Journal of cardiovascular pharmacology, 2003-01, Vol.41 (1), p.140-147

2003

Link zum Volltext

Verfügbarkeit prüfen

Thiazolidinedione Drugs Promote Onset, Alter Characteristics, and Increase Mortality of Ischemic Ventricular Fibrillation in Pigs

Cardiovascular drugs and therapy, 2012-06, Vol.26 (3), p.195-204

2012

Link zum Volltext

Verfügbarkeit prüfen

Bertosamil blocks HERG potassium channels in their open and inactivated states

British journal of pharmacology, 2002-09, Vol.137 (2), p.221-228

2002

Link zum Volltext

Verfügbarkeit prüfen

The gender differences in the relaxation to levosimendan of human internal mammary artery

Cardiovascular drugs and therapy, 2007-10, Vol.21 (5), p.331-338

2007

Link zum Volltext

Verfügbarkeit prüfen

Electrophysiologic Effects of SB-237376: A New Antiarrhythmic Compound with Dual Potassium and Calcium Channel Blocking Action

Journal of cardiovascular pharmacology, 2003-03, Vol.41 (3), p.414-421

2003

Link zum Volltext

Verfügbarkeit prüfen

9‐Amino‐1,2,3,4‐tetrahydroacridine (THA) is a potent blocker of cardiac potassium channels

British journal of pharmacology, 1987-11, Vol.92 (3), p.521-525

Osterrieder, Wolfgang

1987

Link zum Volltext

Verfügbarkeit prüfen

Interaction of potassium channel openers and blockers in canine atrial muscle

British journal of pharmacology, 1989-07, Vol.97 (3), p.753-762

1989

Link zum Volltext

Verfügbarkeit prüfen

Interaction between selected sodium and potassium channel blockers in guinea pig papillary muscle

The Journal of pharmacology and experimental therapeutics, 1993-03, Vol.264 (3), p.1056

1993

Link zum Volltext

Verfügbarkeit prüfen

Synthesis of 4-aryl-3,4-dihydropyrimidin-2(1 H)-thione derivatives as potential calcium channel blockers

Bioorganic & medicinal chemistry, 2006-12, Vol.14 (24), p.8582-8589

2006

Link zum Volltext

Verfügbarkeit prüfen

Treatment of Mild-to-Moderate Hypertension: Comparison Between a Calcium-Channel Blocker and a Potassium-Sparing Diuretic

Journal of cardiovascular pharmacology, 1991, Vol.18 Suppl 9, p.S45-S50

1991

Link zum Volltext

Verfügbarkeit prüfen

Endothelium‐derived hyperpolarizing factor but not NO reduces smooth muscle Ca2+ during acetylcholine‐induced dilation of microvessels

British journal of pharmacology, 1999-09, Vol.128 (1), p.124-134

1999

Link zum Volltext

Verfügbarkeit prüfen

Overlap in the Pharmacology of L-type Ca2+ -channel Blockers and 5-HT2 Receptor Antagonists in Rat Aorta

Journal of pharmacy and pharmacology, 1999-08, Vol.51 (8), p.953-957

Okoro, E. O.

1999

Link zum Volltext

Verfügbarkeit prüfen

Salutary Antiarrhythmic Effect of Combining a K Channel Blocker and a β-Blocker in a Canine Model of 7-Day-Old Myocardial Infarction

Journal of cardiovascular pharmacology, 2000-06, Vol.35 (6), p.914-918

2000

Link zum Volltext

Verfügbarkeit prüfen

Cardiovascular effects of CPU‐23, a novel L‐type calcium channel blocker with a unique molecular structure

British journal of pharmacology, 1997-12, Vol.122 (7), p.1271-1278

1997

Link zum Volltext

Verfügbarkeit prüfen

Mechanisms of nitric oxide‐independent relaxations induced by carbachol and acetylcholine in rat isolated renal arteries

British journal of pharmacology, 2000-07, Vol.130 (6), p.1191-1200

2000

Link zum Volltext

Verfügbarkeit prüfen

Pretreatments with a novel pure potassium channel blocker, nifekalant, were effective in the electrical atrial defibrillation: A report of two cases

Cardiovascular drugs and therapy, 2002-12, Vol.16 (6), p.551-552

2002

Link zum Volltext

Verfügbarkeit prüfen

Calcium channel blocking agents and potassium-stimulated release of glutamate from cerebellar slices

European journal of pharmacology, 1992-12, Vol.229 (1), p.97-99

1992

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of myocardial L- and T-type Ca2+ currents by efonidipine : possible mechanism for its chronotropic effect

European journal of pharmacology, 1998-05, Vol.349 (2-3), p.351-357

1998

Link zum Volltext

Verfügbarkeit prüfen

Blood pressure control with amlodipine add-on therapy in patients with hypertension and diabetes: results of the Amlodipine Diabetic Hypertension Efficacy Response Evaluation Trial

The Annals of pharmacotherapy, 2008-11, Vol.42 (11), p.1552

2008

Link zum Volltext

Verfügbarkeit prüfen

Activation of potassium currents by inhibitors of calcium‐activated chloride conductance in rabbit portal vein smooth muscle cells

British journal of pharmacology, 1996-06, Vol.118 (3), p.513-520

1996

Link zum Volltext

Verfügbarkeit prüfen

Monophosphoryl Lipid A Attenuates Myocardial Stunning in Dogs: Role of ATP-Sensitive Potassium Channels

Journal of cardiovascular pharmacology, 1998-07, Vol.32 (1), p.49-56

1998

Link zum Volltext

Verfügbarkeit prüfen

Levosimendan, a novel Ca2+ sensitizer, activates the glibenclamide-sensitive K+ channel in rat arterial myocytes

European journal of pharmacology, 1997-08, Vol.333 (2-3), p.249-259

1997

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 320

Suche als RSS-Feed

Aktive Filter

ThemaCardiovascular System

ThemaFemale

ThemaLife Sciences & Biomedicine

ThemaPharmacology & Pharmacy

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(284)
Mit Volltextzugriff
(246)

Publikationsform

Artikel
(320)

Sprache

Englisch
(320)
Japanisch
(55)
Deutsch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(320)
Biological And Medical Sciences
(313)
Medical Sciences
(313)
Pharmacology. Drug Treatments
(313)
Male
(286)
Animals
(185)
Humans
(142)
In Vitro Techniques
(114)
Middle Aged
(102)
Cardiovascular System & Cardiology
(86)
Antihypertensive Agents
(82)
Cardiac & Cardiovascular Systems
(82)
Calcium Channel Blockers - Pharmacology
(80)
Adult
(75)
Aged
(75)
Dose-Response Relationship, Drug
(71)

11 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

GPER agonist dilates mesenteric arteries via PI3K-Akt-eNOS and potassium channels in both sexes

Inhibitory effects of cortisone and hydrocortisone on human Kv1.5 channel currents

K+ Channels Expression in Hypertension After Arterial Injury, and Effect of Selective Kv1.3 Blockade with PAP-1 on Intimal Hyperplasia Formation

HMR 1556, A Potent and Selective Blocker of Slowly Activating Delayed Rectifier Potassium Current

Thiazolidinedione Drugs Promote Onset, Alter Characteristics, and Increase Mortality of Ischemic Ventricular Fibrillation in Pigs

Bertosamil blocks HERG potassium channels in their open and inactivated states

The gender differences in the relaxation to levosimendan of human internal mammary artery

Electrophysiologic Effects of SB-237376: A New Antiarrhythmic Compound with Dual Potassium and Calcium Channel Blocking Action

9‐Amino‐1,2,3,4‐tetrahydroacridine (THA) is a potent blocker of cardiac potassium channels

Interaction of potassium channel openers and blockers in canine atrial muscle

Interaction between selected sodium and potassium channel blockers in guinea pig papillary muscle

Synthesis of 4-aryl-3,4-dihydropyrimidin-2(1 H)-thione derivatives as potential calcium channel blockers

Treatment of Mild-to-Moderate Hypertension: Comparison Between a Calcium-Channel Blocker and a Potassium-Sparing Diuretic

Endothelium‐derived hyperpolarizing factor but not NO reduces smooth muscle Ca2+ during acetylcholine‐induced dilation of microvessels

Overlap in the Pharmacology of L-type Ca2+ -channel Blockers and 5-HT2 Receptor Antagonists in Rat Aorta

Salutary Antiarrhythmic Effect of Combining a K Channel Blocker and a β-Blocker in a Canine Model of 7-Day-Old Myocardial Infarction

Cardiovascular effects of CPU‐23, a novel L‐type calcium channel blocker with a unique molecular structure

Mechanisms of nitric oxide‐independent relaxations induced by carbachol and acetylcholine in rat isolated renal arteries

Pretreatments with a novel pure potassium channel blocker, nifekalant, were effective in the electrical atrial defibrillation: A report of two cases

Calcium channel blocking agents and potassium-stimulated release of glutamate from cerebellar slices

Inhibition of myocardial L- and T-type Ca2+ currents by efonidipine : possible mechanism for its chronotropic effect

Blood pressure control with amlodipine add-on therapy in patients with hypertension and diabetes: results of the Amlodipine Diabetic Hypertension Efficacy Response Evaluation Trial

Activation of potassium currents by inhibitors of calcium‐activated chloride conductance in rabbit portal vein smooth muscle cells

Monophosphoryl Lipid A Attenuates Myocardial Stunning in Dogs: Role of ATP-Sensitive Potassium Channels

Levosimendan, a novel Ca2+ sensitizer, activates the glibenclamide-sensitive K+ channel in rat arterial myocytes

Aktive Filter

Suchergebnisse filtern